Skip to main content
Exclusive Savings: Take 10% OFF All Cenmed Products | Upgrade Your Lab For Less Shop Now
US English

ALADDIN SCIENTIFIC

LLL12

LLL12 is a small molecule inhibitor of STAT3 that inhibits STAT3 phosphorylation. LLL12 enhanced the inhibitory effect of Cisplatin and Paclitaxel on ovarian cancer cell formation, migration, and growth.

Description

LLL12 is a small molecule inhibitor of STAT3 that inhibits STAT3 phosphorylation. LLL12 enhanced the inhibitory effect of Cisplatin and Paclitaxel on ovarian cancer cell formation, migration, and growth.


Specifications & Purity: LLL12 is a small molecule inhibitor of STAT3 that inhibits STAT3 phosphorylation. LLL12 enhanced the inhibitory effect of Cisplatin and Paclitaxel on ovarian cancer cell formation, migration, and growth.


Grade: Moligand™


Molecular Weight: 303.29


PubChem CID: 46911017


Isomeric SMILES: C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)N


Storage Temperature: Store at -20°C


Shipped in: Ice chest + Ice pads


Specifications
UPC:
42291702
Weight:
1.09 Ounces
HazmatClass:
Yes
Quantity:
1
Unit of Measurement:
EA
WeightUOM:
LB
MPN:
L611558-1mg
Country of Origin:
China
CAS:
1260247-42-4
Product Size:
1mg
Harmonized Tariff Code:
2931.90.90
Catalog No. C008B-269487
Price: $350.69
List Price: $389.66
  • Guaranteed quality & reliable delivery
  • Shipping Lead-Time: 14-21 Days
Adding to cart… The item has been added
Request a Quote

Enjoy exclusive benefits, including discounted pricing on bulk orders, by opening a Cenmed Business Account. Learn More.